Showing results (1141-1150 of 1,376) with videos related to
Sort By:
Pageof 138
Annals of Internal Medicine|June 5, 2002
Clinical assessment of function among women with a recent cerebrovascular event: a self-reported versus performance-based measurePamela L Owens, Elizabeth H Bradley, Sarah M Horwitz, et al.The Journal of Biological Chemistry|May 4, 2001
Evaluation of the substrate specificity of human mast cell tryptase beta I and demonstration of its importance in bacterial infections of the lungC Huang, G T De Sanctis, P J O'Brien, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 31, 2019
Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantationJamie L Todd, Fran L Kelly, Andrew Nagler, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|March 10, 2019
EGFR-Dependent IL8 Production by Airway Epithelial Cells After Exposure to the Food Flavoring Chemical 2,3-ButanedioneFrancine L Kelly, Kaitlyn E Weinberg, Andrew E Nagler, et al.Journal of Agricultural and Food Chemistry|September 2, 2024
Husk Separation (Kubessa Method) Impacts the Aging Chemistry of BeerStefan A Pieczonka, Lukas Brass, Florian Lehnhardt, et al.Stroke|March 10, 2001
A quality-of-life instrument for young hemorrhagic stroke patientsA G Hamedani, C K Wells, L M Brass, et al.Stroke|May 6, 2003
Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic strokeWalter N Kernan, Silvio E Inzucchi, Catherine M Viscoli, et al.Journal of Bacteriology|November 1, 1996
GlbN (cyanoglobin) is a peripheral membrane protein that is restricted to certain Nostoc sppD R Hill, T J Belbin, M V Thorsteinsson, et al.Journal of Cardiovascular Electrophysiology|July 29, 2010
A novel mutation in the HCN4 gene causes symptomatic sinus bradycardia in Moroccan JewsAvishag Laish-Farkash, Michael Glikson, Dovrat Brass, et al.Antimicrobial Agents and Chemotherapy|April 2, 2014
The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistanceUdayan Chatterji, Jose A Garcia-Rivera, James Baugh, et al.Pageof 138